Pfizer Inc. (PFE), Puma Biotechnology Inc (PBYI): Strong Product Pipelines Have Pharmaceutical Companies Poised for Growth

Page 1 of 2

With the global economy beginning to stabilize, the stock market is looking more attractive than ever. One industry that could stand to make huge gains in the near future is the pharmaceutical industry, though it’s worth noting that this sector is a high risk, high reward industry. Still, pharmaceutical stocks offer a great way to diversify your portfolio and add stocks with high potential. Yes, there are risks involved, but having some higher risk stocks in your portfolio can increase long-term growth potential.

This is especially true for start-up companies which offer the highest potential for returns, but also the greatest risk for losses. Some start-ups will make major breakthroughs and produce huge profits, other start ups will simply fail and fold. If start-ups aren’t your thing, you can invest in larger, more stable companies, such as Pfizer Inc. (NYSE:PFE), which have more diverse product line-ups and revenue streams.

Pfizer Inc. (NYSE:PFE)

You should also examine mid-sized companies that offer a good mix of reward and risk. Still, if a major lawsuit comes out, or a pivotal drug fails to pass clinical trials, stock prices can swing wildly no matter which company you are invested in.

A young, aggressive start up

One company that has the potential to produce strong future returns is Puma Biotechnology Inc (NYSE:PBYI). The company’s stock price has grown nearly 200% in the last year and it currently has a market cap of just over $1 billion. The company has plenty of room to grow, and with its primary product, PB272 (neratinib), now entering phase III of the trial phase, there is a chance that the stock could explode.

This will depend largely on whether PB272, a breast cancer treatment, proves effective, though early tests and research suggests that it will. If you are looking to add a high risk, high reward stock to your portfolio, Puma Biotechnology Inc (NYSE:PBYI) deserves a close examination.

A diversified multinational with growth potential

If you are looking for a safer company, Pfizer Inc. (NYSE:PFE) offers a chance to invest in a diversified multi-billion dollar company. With a market cap of just over $200 billion, Pfizer Inc. (NYSE:PFE) certainly doesn’t count as a start-up. Still, with a trailing P/E of 13.45 and a profit margin of nearly 27%, the company appears to be positioned for strong future growth.

Some investors might be wary of the $40 billion worth of debt, but Pfizer Inc. (NYSE:PFE) maintains $35.41 billion cash-in-hand. Pfizer Inc. (NYSE:PFE) also has several interesting new products in the market, including Xalkori, which has proven in trials to halt the worsening of lung cancer, and has thus far shown to be more effective than chemotherapy.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!